InnovAge Holding Corp

INNV remains in a Stage 2 advancing uptrend with a recent Momentum Breakout confirming fresh demand, but price is extended far above rising EMAs with extreme overbought conditions. Medium-term bias stays bullish, yet near-term timing is unfavorable. Defer execution and wait for a pullback into the 9/21 EMA zone or the prior resistance-turned-support area for optimal entry.

• ↑Q3 revenue of $252M (+15.5% YoY) driven by higher capitation rates
• ↑Adjusted EBITDA margin rose to 12.1%, up 730bps on operational efficiencies
• ↓Q3 net loss of $29.9M underscores profitability challenges